跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 116,526 条关于
“dMMR/MSI-H rectal cancer”
全部
116,526
临床试验
95,985
药物
3,302
机构
1,406
资讯
15,833
去年
FDA Grants Breakthrough Therapy Designation to GSK's Jemperli for Advanced Rectal Cancer
去年
GSK's Cancer Portfolio Gains Momentum with Regulatory Successes for Dostarlimab and GSK'227
11个月前
AnaptysBio Plans Corporate Split to Separate Royalty Assets from Drug Development Operations
去年
Nivolumab Plus Ipilimumab Demonstrates Superior PFS in MSI-H/dMMR Metastatic Colorectal Cancer
去年
Error parsing response
去年
Optimizing Neoadjuvant Immunotherapy Strategies in Colorectal Cancer
去年
Nivolumab Shows Promising Results in dMMR/MSI-H Endometrial Cancer, Potentially Eliminating Need for Surgery
去年
FDA Accepts Nivolumab-Ipilimumab Combination for First-line Treatment of dMMR/MSI-H Colorectal Cancer
9个月前
Bristol Myers Squibb's OPDIVO Plus YERVOY Receives Positive Reimbursement Recommendation for MSI-H/dMMR Colorectal Cancer in Canada
3年前
EMA Recommends Nivolumab and Ipilimumab Combination for dMMR/MSI-H Metastatic Colorectal Cancer
第 1 页,共 1584 页
上一页
下一页